This clinical trial investigates the safety, feasibility, and therapeutic potential of a combined approach using HiCM-188 cardiomyocyte injection delivered intramyocardially alongside either LVAD implantation or CABG surgery in patients with advanced ischemic heart failure.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
6-minute walk test
Timeframe: baseline, 1, 3, 6, 12 months post-operation
Major Adverse Cardiovascular Events
Timeframe: From enrollment to the end of study at 12 months
Survival rate
Timeframe: From enrollment to the end of study at 12 months